Literature DB >> 20715179

Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette.

Aba Somers1, Jyh-Chang Jean, Cesar A Sommer, Amel Omari, Christopher C Ford, Jason A Mills, Lei Ying, Andreia Gianotti Sommer, Jenny M Jean, Brenden W Smith, Robert Lafyatis, Marie-France Demierre, Daniel J Weiss, Deborah L French, Paul Gadue, George J Murphy, Gustavo Mostoslavsky, Darrell N Kotton.   

Abstract

The development of methods to achieve efficient reprogramming of human cells while avoiding the permanent presence of reprogramming transgenes represents a critical step toward the use of induced pluripotent stem cells (iPSC) for clinical purposes, such as disease modeling or reconstituting therapies. Although several methods exist for generating iPSC free of reprogramming transgenes from mouse cells or neonatal normal human tissues, a sufficiently efficient reprogramming system is still needed to achieve the widespread derivation of disease-specific iPSC from humans with inherited or degenerative diseases. Here, we report the use of a humanized version of a single lentiviral "stem cell cassette" vector to accomplish efficient reprogramming of normal or diseased skin fibroblasts obtained from humans of virtually any age. Simultaneous transfer of either three or four reprogramming factors into human target cells using this single vector allows derivation of human iPSC containing a single excisable viral integration that on removal generates human iPSC free of integrated transgenes. As a proof of principle, here we apply this strategy to generate >100 lung disease-specific iPSC lines from individuals with a variety of diseases affecting the epithelial, endothelial, or interstitial compartments of the lung, including cystic fibrosis, α-1 antitrypsin deficiency-related emphysema, scleroderma, and sickle-cell disease. Moreover, we demonstrate that human iPSC generated with this approach have the ability to robustly differentiate into definitive endoderm in vitro, the developmental precursor tissue of lung epithelia.

Entities:  

Mesh:

Year:  2010        PMID: 20715179      PMCID: PMC3422663          DOI: 10.1002/stem.495

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  39 in total

1.  Efficient differentiation of human embryonic stem cells to definitive endoderm.

Authors:  Kevin A D'Amour; Alan D Agulnick; Susan Eliazer; Olivia G Kelly; Evert Kroon; Emmanuel E Baetge
Journal:  Nat Biotechnol       Date:  2005-10-28       Impact factor: 54.908

Review 2.  Regulation of early lung morphogenesis: questions, facts and controversies.

Authors:  Wellington V Cardoso; Jining Lü
Journal:  Development       Date:  2006-05       Impact factor: 6.868

Review 3.  Airway gene therapy.

Authors:  Jane C Davies; Eric W F W Alton
Journal:  Adv Genet       Date:  2005       Impact factor: 1.944

4.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

5.  BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm.

Authors:  Valerie Gouon-Evans; Lise Boussemart; Paul Gadue; Dirk Nierhoff; Christoph I Koehler; Atsushi Kubo; David A Shafritz; Gordon Keller
Journal:  Nat Biotechnol       Date:  2006-11-05       Impact factor: 54.908

6.  Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells.

Authors:  Paul Gadue; Tara L Huber; Patrick J Paddison; Gordon M Keller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

7.  Development of definitive endoderm from embryonic stem cells in culture.

Authors:  Atsushi Kubo; Katsunori Shinozaki; John M Shannon; Valerie Kouskoff; Marion Kennedy; Savio Woo; Hans Joerg Fehling; Gordon Keller
Journal:  Development       Date:  2004-03-03       Impact factor: 6.868

8.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

9.  Abnormal pulmonary function in adults with sickle cell anemia.

Authors:  Elizabeth S Klings; Diego F Wyszynski; Vikki G Nolan; Martin H Steinberg
Journal:  Am J Respir Crit Care Med       Date:  2006-03-23       Impact factor: 21.405

10.  Nodal antagonists regulate formation of the anteroposterior axis of the mouse embryo.

Authors:  Masamichi Yamamoto; Yukio Saijoh; Aitana Perea-Gomez; William Shawlot; Richard R Behringer; Siew-Lan Ang; Hiroshi Hamada; Chikara Meno
Journal:  Nature       Date:  2004-03-07       Impact factor: 49.962

View more
  195 in total

Review 1.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

2.  Developmental and functional nature of human iPSC derived motoneurons.

Authors:  Marianne Stockmann; Leonhard Linta; Karl J Föhr; Anja Boeckers; Albert C Ludolph; Georges F Kuh; Patrick T Udvardi; Christian Proepper; Alexander Storch; Alexander Kleger; Stefan Liebau; Tobias M Boeckers
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

3.  Putting stem cells to the test.

Authors:  Elie Dolgin
Journal:  Nat Med       Date:  2010-12       Impact factor: 53.440

Review 4.  Human-induced pluripotent stem cells: in quest of clinical applications.

Authors:  Rosalinda Madonna
Journal:  Mol Biotechnol       Date:  2012-10       Impact factor: 2.695

Review 5.  Human induced pluripotent stem cells--from mechanisms to clinical applications.

Authors:  Katharina Drews; Justyna Jozefczuk; Alessandro Prigione; James Adjaye
Journal:  J Mol Med (Berl)       Date:  2012-05-30       Impact factor: 4.599

6.  Productive Infection of Human Embryonic Stem Cell-Derived NKX2.1+ Respiratory Progenitors with Human Rhinovirus.

Authors:  Robert A Jenny; Claire Hirst; Sue Mei Lim; Adam L Goulburn; Suzanne J Micallef; Tanya Labonne; Anthony Kicic; Kak-Ming Ling; Stephen M Stick; Elizabeth S Ng; Alan Trounson; Antonietta Giudice; Andrew G Elefanty; Edouard G Stanley
Journal:  Stem Cells Transl Med       Date:  2015-04-14       Impact factor: 6.940

Review 7.  Induced pluripotent stem cells: the new patient?

Authors:  Milena Bellin; Maria C Marchetto; Fred H Gage; Christine L Mummery
Journal:  Nat Rev Mol Cell Biol       Date:  2012-10-04       Impact factor: 94.444

8.  Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells.

Authors:  Johannes Kuehle; Soeren Turan; Tobias Cantz; Dirk Hoffmann; Julia D Suerth; Tobias Maetzig; Daniela Zychlinski; Christoph Klein; Doris Steinemann; Christopher Baum; Juergen Bode; Axel Schambach
Journal:  Mol Ther       Date:  2014-01-17       Impact factor: 11.454

9.  Derivation and characterization of a transgene-free human induced pluripotent stem cell line and conversion into defined clinical-grade conditions.

Authors:  Jason P Awe; Agustin Vega-Crespo; James A Byrne
Journal:  J Vis Exp       Date:  2014-11-26       Impact factor: 1.355

10.  Metabolic control of primed human pluripotent stem cell fate and function by the miR-200c-SIRT2 axis.

Authors:  Young Cha; Min-Joon Han; Hyuk-Jin Cha; Janet Zoldan; Alison Burkart; Jin Hyuk Jung; Yongwoo Jang; Chun-Hyung Kim; Ho-Chang Jeong; Byung-Gyu Kim; Robert Langer; C Ronald Kahn; Leonard Guarente; Kwang-Soo Kim
Journal:  Nat Cell Biol       Date:  2017-04-24       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.